Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V G Vogel

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Clinical Breast Cancer|March 20, 2002
Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials: an alternative viewJ P Costantino, V G Vogel
Current Opinion in Oncology|January 1, 1993
Epidemiology and etiology of leukemiaV G Vogel, R E Fisher
Breast Cancer Research and Treatment|November 1, 1993
Clinical management of women at increased risk for breast cancerV G Vogel, A Yeomans, E Higginbotham
AJR. American Journal of Roentgenology|January 1, 1992
Design and conduct of a low-cost mammography screening project: experience of the American Cancer Society, Texas DivisionV G Vogel, G N Peters, W P Evans
Oncology (Williston Park, N.Y.)|March 1, 1996
Economic savings and costs of periodic mammographic screening in the workplaceR I Griffiths, M M McGrath, V G Vogel
Cancer Letters|January 1, 1990
Inhibition of protein kinase C by the 12-O-tetradecanoylphorbol-13-acetate antagonist glycyrrhetic acidC A O'Brian, N E Ward, V G Vogel
Cancer Research|June 15, 1989
Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissueC O'Brian, V G Vogel, S E Singletary, et al.
Breast Cancer Research and Treatment|November 1, 1993
Factors associated with perceived risk of breast cancer among women attending a screening programS W Vernon, V G Vogel, S Halabi, et al.
Cancer Detection and Prevention|January 1, 1993
Recruiting older women for screening mammographyS Halabi, V G Vogel, M L Bondy, et al.
Preventive Medicine|November 11, 1998
The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention TrialA Y Kinney, C Richards, S W Vernon, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Clinical Breast Cancer|March 20, 2002
Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials: an alternative viewJ P Costantino, V G Vogel
Current Opinion in Oncology|January 1, 1993
Epidemiology and etiology of leukemiaV G Vogel, R E Fisher
Breast Cancer Research and Treatment|November 1, 1993
Clinical management of women at increased risk for breast cancerV G Vogel, A Yeomans, E Higginbotham
AJR. American Journal of Roentgenology|January 1, 1992
Design and conduct of a low-cost mammography screening project: experience of the American Cancer Society, Texas DivisionV G Vogel, G N Peters, W P Evans
Oncology (Williston Park, N.Y.)|March 1, 1996
Economic savings and costs of periodic mammographic screening in the workplaceR I Griffiths, M M McGrath, V G Vogel
Cancer Letters|January 1, 1990
Inhibition of protein kinase C by the 12-O-tetradecanoylphorbol-13-acetate antagonist glycyrrhetic acidC A O'Brian, N E Ward, V G Vogel
Cancer Research|June 15, 1989
Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissueC O'Brian, V G Vogel, S E Singletary, et al.
Breast Cancer Research and Treatment|November 1, 1993
Factors associated with perceived risk of breast cancer among women attending a screening programS W Vernon, V G Vogel, S Halabi, et al.
Cancer Detection and Prevention|January 1, 1993
Recruiting older women for screening mammographyS Halabi, V G Vogel, M L Bondy, et al.
Preventive Medicine|November 11, 1998
The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention TrialA Y Kinney, C Richards, S W Vernon, et al.
Pageof 5